by bmi_wpadmin | Jul 14, 2022 | BayMedica
Jerry P. Griffin, VP of Sales and Marketing at BayMedica, InMed’s subsidiary, is interviewed by Shadd Dales of The Dales Report to talk about the recent B2B sales launch of rare cannabinoid D9 THCV (Tetrahydrocannabivarin) into the health and wellness sector. Full...
Recent Comments